Expertise
Internationally recognized leaders in the field, PCCTC investigators come from the nation’s top academic medical centers where they are actively engaged in world class science through cutting-edge translational prostate cancer research.
The PCCTC was formed to address critically unmet needs in prostate cancer. Our mission is to design, implement, and complete early-phase process driven clinical trials, translating scientific discoveries to improved standards of care.
The PCCTC is changing how prostate cancer drugs are developed. Our unique infrastructure facilitates project co-development between investigators, clinical research sites and industry partners.
Internationally recognized leaders in the field, PCCTC investigators come from the nation’s top academic medical centers where they are actively engaged in world class science through cutting-edge translational prostate cancer research.
NORTH BILLERICA, MA, January 27, 2022 – Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus...
Learn MoreThe Prostate Cancer Clinical Trials Consortium (PCCTC) Genetics Germline Working Group is ...
Learn MoreThe Prostate Cancer Clinical Trials Consortium (PCCTC) was initiated in 2005 by the Prosta...
Learn MoreResearchers from Johns Hopkins University, University of Washington School of Medicine see...
Learn MoreJoin our team of dedicated clinical research professionals! The Prostate Cancer Clinical Trials Consortium is currently seeking a Quality Manager and Clinical Data Manager to help fulfill our…
Our services translate scientific discoveries into improved standards of care, ensuring efficient trial selection, reporting, site management, clinical operations and data analyses.